
Marksans Pharma Investor Relations Material
Latest events

Q1 25/26
Marksans Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Marksans Pharma Limited
Access all reports
Marksans Pharma Limited is a pharmaceutical company engaged in the research, manufacturing, and marketing of generic pharmaceutical formulations. The company produces a wide range of dosage forms including tablets, capsules, liquids, and ointments across therapeutic areas such as pain management, gastrointestinal, cardiovascular, and anti-infective segments. It serves regulated and semi-regulated markets including the United States, Europe, Australia, and emerging regions. Marksans Pharma Limited operates manufacturing facilities compliant with global regulatory standards and offers contract manufacturing services. The company is headquartered in Mumbai, India, and its shares are listed on the BSE.
Key slides for Marksans Pharma Limited


Q1 25/26
Marksans Pharma Limited


Q1 25/26
Marksans Pharma Limited
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
MARKSANS
Country
🇮🇳 India